<scp>CAPN1</scp> promotes malignant behavior and erlotinib resistance mediated by phosphorylation of <scp>c‐Met</scp> and <scp>PIK3R2</scp><i>via</i> degrading <scp>PTPN1</scp> in lung adenocarcinomaYi-Chuan Chen, Fang Liu, Jingqun Tang et al.|Thoracic Cancer|2020Cited by 24